seroquel prolong 150 mg depottabletter
cheplapharm arzneimittel gmbh - quetiapin fumarat - depottabletter - 150 mg
seroquel prolong 200 mg depottabletter
cheplapharm arzneimittel gmbh - quetiapin fumarat - depottabletter - 200 mg
seroquel prolong 300 mg depottabletter
cheplapharm arzneimittel gmbh - quetiapin fumarat - depottabletter - 300 mg
seroquel prolong 300 mg depottabletter
abacus medicine a/s - quetiapin fumarat - depottabletter - 300 mg
seroquel prolong 400 mg depottabletter
cheplapharm arzneimittel gmbh - quetiapin fumarat - depottabletter - 400 mg
seroquel prolong 200 mg depottabletter
abacus medicine a/s - quetiapin fumarat - depottabletter - 200 mg
seroquel prolong 400 mg depottabletter
abacus medicine a/s - quetiapin fumarat - depottabletter - 400 mg
seroquel prolong 150 mg depottabletter
abacus medicine a/s - quetiapin fumarat - depottabletter - 150 mg
revolade
novartis europharm limited - eltrombopag - purpura, trombocytopenisk, idiopatisk - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 og 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 og 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
apidra
sanofi-aventis deutschland gmbh - insulin glulisin - diabetes mellitus - narkotika anvendt i diabetes - behandling af voksne, unge og børn, seks år eller ældre med diabetes mellitus, hvor insulinbehandling er nødvendig.